Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (161-170 of 6,821) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|November 27, 2023
CRISPR gets the glory in landmark approval, but haemoglobin research made it possibleAsher Mullard
Nature Reviews. Drug Discovery|December 4, 2023
FDA approves first chikungunya vaccineAsher Mullard
Nature Reviews. Drug Discovery|February 28, 2015
Fragile X disappointments upset autism ambitionsAsher Mullard
Nature Reviews. Drug Discovery|July 2, 2014
GSK's darapladib failures dim hopes for anti-inflammatory heart drugsAsher Mullard
Nature Reviews. Drug Discovery|June 2, 2023
PD1 agonist antibody passes first phase II trial for autoimmune diseaseAsher Mullard
Nature Reviews. Drug Discovery|May 16, 2023
NCATS's plan to grow the rare disease pipelineAsher Mullard
Nature Reviews. Drug Discovery|May 17, 2023
NfL makes regulatory debut as neurodegenerative disease biomarkerAsher Mullard
Nature Reviews. Drug Discovery|May 19, 2023
FDA approves first-in-class NK3 receptor antagonist for hot flushesAsher Mullard
Nature Reviews. Drug Discovery|November 10, 2023
Biotechs step on cGAS for autoimmune diseasesAsher Mullard
Nature Reviews. Drug Discovery|August 7, 2025
Leading orexin receptor agonist clears phase III for narcolepsyAsher Mullard
Pageof 683

Showing results (161-170 of 6,821) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|November 27, 2023
CRISPR gets the glory in landmark approval, but haemoglobin research made it possibleAsher Mullard
Nature Reviews. Drug Discovery|December 4, 2023
FDA approves first chikungunya vaccineAsher Mullard
Nature Reviews. Drug Discovery|February 28, 2015
Fragile X disappointments upset autism ambitionsAsher Mullard
Nature Reviews. Drug Discovery|July 2, 2014
GSK's darapladib failures dim hopes for anti-inflammatory heart drugsAsher Mullard
Nature Reviews. Drug Discovery|June 2, 2023
PD1 agonist antibody passes first phase II trial for autoimmune diseaseAsher Mullard
Nature Reviews. Drug Discovery|May 16, 2023
NCATS's plan to grow the rare disease pipelineAsher Mullard
Nature Reviews. Drug Discovery|May 17, 2023
NfL makes regulatory debut as neurodegenerative disease biomarkerAsher Mullard
Nature Reviews. Drug Discovery|May 19, 2023
FDA approves first-in-class NK3 receptor antagonist for hot flushesAsher Mullard
Nature Reviews. Drug Discovery|November 10, 2023
Biotechs step on cGAS for autoimmune diseasesAsher Mullard
Nature Reviews. Drug Discovery|August 7, 2025
Leading orexin receptor agonist clears phase III for narcolepsyAsher Mullard
Pageof 683